Reference:
1. Liverpool Drug Interactions Group. Evaluating the drug-drug interaction risk of experimental COVID-19 therapies. [Internet]. 2020. [cited 28 November 2022]. Available from: https://www.lpnh.go.th/files/drug/Covid_drugs%20DI%20Metabolism_Web_2020_Apr03.pdf
2. Micromedex. Dolutegravir Sodium. [Database on the internet]. [cited 28 November 2022]. Available from: https://www-micromedexsolutions-com.ejournal.mahidol.ac.th/micromedex2/librarian/PFDefaultActionId/evidencexpert.DoIntegratedSearch?navitem=headerLogout#
3. National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. [Internet]. 2022. [cited 28 November 2022]. Available from: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
4. Centers for Disease Control and Prevention. HIV and COVID-19 Basics. [Internet]. 2022. [cited 28 November 2022]. Available from: https://www.cdc.gov/hiv/basics/covid-19.html
Keywords:
โควิด 19, HIV, dolutegravir, tenofovir, lamivudine, molnupiravir, favipiravir
